APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cadonilimab Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cadonilimab Injection Market Outlook and Growth Opportunities 2026

Report ID 173973640427 December 2025197 pages

Choose your research edition.

Industry ResearchCadonilimab Injection Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Cadonilimab Injection Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Cadonilimab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cadonilimab Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cadonilimab Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cadonilimab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cadonilimab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cadonilimab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cadonilimab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cadonilimab Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cadonilimab Injection market include Akeso Inc.. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cadonilimab Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cadonilimab Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cadonilimab Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cadonilimab Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cadonilimab Injection Segment by Company

Akeso Inc.

Cadonilimab Injection Segment by Type

125 mg (10 mL)/Bottle

Other

Cadonilimab Injection Segment by Application

Lung Cancer

Liver Cancer

Cervical Cancer

Gastric Cancer

Pancreatic Cancer

Other

Cadonilimab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cadonilimab Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cadonilimab Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cadonilimab Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Cadonilimab Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cadonilimab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cadonilimab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cadonilimab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cadonilimab Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cadonilimab Injection industry.

Chapter 3: Detailed analysis of Cadonilimab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cadonilimab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cadonilimab Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cadonilimab Injection Industry Trends Table 2. Cadonilimab Injection Industry Drivers Table 3. Cadonilimab Injection Industry Opportunities and Challenges Table 4. Cadonilimab Injection Industry Restraints Table 5. Global Cadonilimab Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cadonilimab Injection Revenue Share by Company (2021-2026) Table 7. Global Cadonilimab Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Cadonilimab Injection Sales Volume Share by Company (2021-2026) Table 9. Global Cadonilimab Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Cadonilimab Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cadonilimab Injection Key Company Manufacturing Base & Headquarters Table 12. Global Cadonilimab Injection Company, Product Type & Application Table 13. Global Cadonilimab Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cadonilimab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 125 mg (10 mL)/Bottle Table 18. Significant Companies of Other Table 19. Global Cadonilimab Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Cadonilimab Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Cadonilimab Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Cadonilimab Injection Sales Volume Share by Type (2021-2026) Table 23. Global Cadonilimab Injection Sales Volume Share by Type (2027-2032) Table 24. Global Cadonilimab Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cadonilimab Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cadonilimab Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cadonilimab Injection Sales Value Share by Type (2021-2026) Table 28. Global Cadonilimab Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Lung Cancer Table 30. Significant Companies of Liver Cancer Table 31. Significant Companies of Cervical Cancer Table 32. Significant Companies of Gastric Cancer Table 33. Significant Companies of Pancreatic Cancer Table 34. Significant Companies of Other Table 35. Global Cadonilimab Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Cadonilimab Injection Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Cadonilimab Injection Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Cadonilimab Injection Sales Volume Share by Application (2021-2026) Table 39. Global Cadonilimab Injection Sales Volume Share by Application (2027-2032) Table 40. Global Cadonilimab Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Cadonilimab Injection Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Cadonilimab Injection Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Cadonilimab Injection Sales Value Share by Application (2021-2026) Table 44. Global Cadonilimab Injection Sales Value Share by Application (2027-2032) Table 45. Global Cadonilimab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Cadonilimab Injection Sales by Region (2021-2026) & (K Units) Table 47. Global Cadonilimab Injection Sales Market Share by Region (2021-2026) Table 48. Global Cadonilimab Injection Sales by Region (2027-2032) & (K Units) Table 49. Global Cadonilimab Injection Sales Market Share by Region (2027-2032) Table 50. Global Cadonilimab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Cadonilimab Injection Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Cadonilimab Injection Sales Value Share by Region (2021-2026) Table 53. Global Cadonilimab Injection Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Cadonilimab Injection Sales Value Share by Region (2027-2032) Table 55. Global Cadonilimab Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Cadonilimab Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Cadonilimab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Cadonilimab Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cadonilimab Injection Sales by Country (2021-2026) & (K Units) Table 60. Global Cadonilimab Injection Sales Market Share by Country (2021-2026) Table 61. Global Cadonilimab Injection Sales by Country (2027-2032) & (K Units) Table 62. Global Cadonilimab Injection Sales Market Share by Country (2027-2032) Table 63. Global Cadonilimab Injection Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Cadonilimab Injection Sales Value Market Share by Country (2021-2026) Table 65. Global Cadonilimab Injection Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Cadonilimab Injection Sales Value Market Share by Country (2027-2032) Table 67. Akeso Inc. Company Information Table 68. Akeso Inc. Business Overview Table 69. Akeso Inc. Cadonilimab Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Akeso Inc. Cadonilimab Injection Product Portfolio Table 71. Akeso Inc. Recent Development Table 72. Key Raw Materials Table 73. Raw Materials Key Suppliers Table 74. Cadonilimab Injection Distributors List Table 75. Cadonilimab Injection Customers List Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Cadonilimab Injection Product Image Figure 2. Global Cadonilimab Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cadonilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cadonilimab Injection Sales (2021-2032) & (K Units) Figure 5. Global Cadonilimab Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Cadonilimab Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 125 mg (10 mL)/Bottle Image Figure 10. Other Image Figure 11. Global Cadonilimab Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Cadonilimab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cadonilimab Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Cadonilimab Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cadonilimab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cadonilimab Injection Sales Value Share by Type (2021-2032) Figure 17. Lung Cancer Image Figure 18. Liver Cancer Image Figure 19. Cervical Cancer Image Figure 20. Gastric Cancer Image Figure 21. Pancreatic Cancer Image Figure 22. Other Image Figure 23. Global Cadonilimab Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Cadonilimab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Cadonilimab Injection Sales Volume Share by Application (2021-2032) Figure 26. Global Cadonilimab Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Cadonilimab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Cadonilimab Injection Sales Value Share by Application (2021-2032) Figure 29. Global Cadonilimab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Cadonilimab Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Cadonilimab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Cadonilimab Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Cadonilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 34. North America Cadonilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Cadonilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Cadonilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Cadonilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Cadonilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Cadonilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 40. South America Cadonilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Cadonilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Cadonilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Cadonilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Cadonilimab Injection Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Cadonilimab Injection Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 125 mg (10 mL)/Bottle
  • Other
Applications
  • Lung Cancer
  • Liver Cancer
  • Cervical Cancer
  • Gastric Cancer
  • Pancreatic Cancer
  • Other
Companies covered
  • Akeso Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cadonilimab Injection Sales Value (2021-2032)
  4. 1.2.2 Global Cadonilimab Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Cadonilimab Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cadonilimab Injection Market Dynamics
  1. 2.1 Cadonilimab Injection Industry Trends
  2. 2.2 Cadonilimab Injection Industry Drivers
  3. 2.3 Cadonilimab Injection Industry Opportunities and Challenges
  4. 2.4 Cadonilimab Injection Industry Restraints
3 Cadonilimab Injection Market by Company
  1. 3.1 Global Cadonilimab Injection Company Revenue Ranking in 2025
  2. 3.2 Global Cadonilimab Injection Revenue by Company (2021-2026)
  3. 3.3 Global Cadonilimab Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Cadonilimab Injection Average Price by Company (2021-2026)
  5. 3.5 Global Cadonilimab Injection Company Ranking (2024-2026)
  6. 3.6 Global Cadonilimab Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Cadonilimab Injection Company Product Type and Application
  8. 3.8 Global Cadonilimab Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cadonilimab Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cadonilimab Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cadonilimab Injection Market by Type
  1. 4.1 Cadonilimab Injection Type Introduction
  2. 4.1.1 125 mg (10 mL)/Bottle
  3. 4.1.2 Other
  4. 4.2 Global Cadonilimab Injection Sales Volume by Type
  5. 4.2.1 Global Cadonilimab Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cadonilimab Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cadonilimab Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cadonilimab Injection Sales Value by Type
  9. 4.3.1 Global Cadonilimab Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cadonilimab Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cadonilimab Injection Sales Value Share by Type (2021-2032)
5 Cadonilimab Injection Market by Application
  1. 5.1 Cadonilimab Injection Application Introduction
  2. 5.1.1 Lung Cancer
  3. 5.1.2 Liver Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Gastric Cancer
  6. 5.1.5 Pancreatic Cancer
  7. 5.1.6 Other
  8. 5.2 Global Cadonilimab Injection Sales Volume by Application
  9. 5.2.1 Global Cadonilimab Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Cadonilimab Injection Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Cadonilimab Injection Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Cadonilimab Injection Sales Value by Application
  13. 5.3.1 Global Cadonilimab Injection Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Cadonilimab Injection Sales Value by Application (2021-2032)
  15. 5.3.3 Global Cadonilimab Injection Sales Value Share by Application (2021-2032)
6 Cadonilimab Injection Regional Sales and Value Analysis
  1. 6.1 Global Cadonilimab Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cadonilimab Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cadonilimab Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Cadonilimab Injection Sales by Region (2027-2032)
  5. 6.3 Global Cadonilimab Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cadonilimab Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cadonilimab Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cadonilimab Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Cadonilimab Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cadonilimab Injection Sales Value (2021-2032)
  12. 6.6.2 North America Cadonilimab Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cadonilimab Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Cadonilimab Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cadonilimab Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cadonilimab Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cadonilimab Injection Sales Value (2021-2032)
  21. 6.9.2 South America Cadonilimab Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cadonilimab Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cadonilimab Injection Sales Value Share by Country, 2025 VS 2032
7 Cadonilimab Injection Country-level Sales and Value Analysis
  1. 7.1 Global Cadonilimab Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cadonilimab Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cadonilimab Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Cadonilimab Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Cadonilimab Injection Sales by Country (2027-2032)
  6. 7.4 Global Cadonilimab Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cadonilimab Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cadonilimab Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cadonilimab Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cadonilimab Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cadonilimab Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akeso Inc.
  2. 8.1.1 Akeso Inc. Company Information
  3. 8.1.2 Akeso Inc. Business Overview
  4. 8.1.3 Akeso Inc. Cadonilimab Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Akeso Inc. Cadonilimab Injection Product Portfolio
  6. 8.1.5 Akeso Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cadonilimab Injection Value Chain Analysis
  2. 9.1.1 Cadonilimab Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cadonilimab Injection Sales Mode & Process
  6. 9.2 Cadonilimab Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cadonilimab Injection Distributors
  9. 9.2.3 Cadonilimab Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst